In Vitro Activity of the New Glycopeptide LY333328 against Multiply Resistant Gram-Positive Clinical Isolates

The in vitro activity of LY333328 was compared with those of vancomycin and teicoplanin against 425 gram-positive clinical isolates, including a variety of multiply resistant strains. LY333328 at ≤4 μg/ml inhibited all microorganisms tested, including methicillin- and teicoplanin-resistant staphyloc...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	García-Garrote, Fernando, Cercenado, Emilia, Alcalá, Luis, Bouza, Emilio
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105854/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9736584/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.9.2452
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!